NASDAQ:ADMP
$2.07
(
-0.96%
)
Friday, 2nd Jun 2023
Adamis Pharmaceuticals Corporation Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $0.0476 | $3.87 | Friday, 2nd Jun 2023 ADMP stock ended at $2.07. This is 0.96% less than the trading day before Thursday, 1st Jun 2023. During the day the stock fluctuated 6.93% from a day low at $2.02 to a day high of $2.16. |
| 90 days | $0.0476 | $3.87 | |
| 52 weeks | $0.0476 | $3.87 |
Historical Adamis Pharmaceuticals Corporation prices
| Date | Open | High | Low | Close | Volume |
| 2023-06-02 | $2.11 | $2.16 | $2.02 | $2.07 | 45 611 |
| 2023-06-01 | $2.09 | $2.13 | $2.05 | $2.09 | 46 432 |
| 2023-05-31 | $2.13 | $2.13 | $2.00 | $2.09 | 60 566 |
| 2023-05-30 | $2.07 | $2.15 | $2.00 | $2.12 | 89 388 |
| 2023-05-26 | $2.01 | $2.60 | $1.91 | $2.07 | 911 967 |
| 2023-05-25 | $2.77 | $2.81 | $2.50 | $2.50 | 73 367 |
| 2023-05-24 | $2.83 | $2.94 | $2.67 | $2.77 | 94 902 |
| 2023-05-23 | $3.19 | $3.22 | $2.81 | $2.82 | 136 926 |
| 2023-05-22 | $3.24 | $3.87 | $3.10 | $3.19 | 291 696 |
| 2023-05-19 | $0.0700 | $0.0708 | $0.0476 | $0.0500 | 12 965 412 |
| 2023-05-18 | $0.0670 | $0.0700 | $0.0655 | $0.0680 | 1 380 590 |
| 2023-05-17 | $0.0735 | $0.0735 | $0.0620 | $0.0660 | 1 861 315 |
| 2023-05-16 | $0.0850 | $0.0850 | $0.0631 | $0.0695 | 2 241 592 |
| 2023-05-15 | $0.0817 | $0.0820 | $0.0679 | $0.0700 | 2 209 263 |
| 2023-05-12 | $0.0780 | $0.0830 | $0.0775 | $0.0790 | 1 274 267 |
| 2023-05-11 | $0.0900 | $0.0909 | $0.0770 | $0.0800 | 3 219 807 |
| 2023-05-10 | $0.0763 | $0.0813 | $0.0700 | $0.0800 | 2 352 396 |
| 2023-05-09 | $0.0728 | $0.0728 | $0.0678 | $0.0700 | 1 344 725 |
| 2023-05-08 | $0.0680 | $0.0753 | $0.0680 | $0.0711 | 1 238 544 |
| 2023-05-05 | $0.0757 | $0.0800 | $0.0692 | $0.0700 | 919 657 |
| 2023-05-04 | $0.0800 | $0.0816 | $0.0752 | $0.0780 | 1 034 484 |
| 2023-05-03 | $0.0818 | $0.0818 | $0.0742 | $0.0760 | 682 527 |
| 2023-05-02 | $0.0804 | $0.0835 | $0.0700 | $0.0811 | 1 340 534 |
| 2023-05-01 | $0.0810 | $0.0896 | $0.0755 | $0.0804 | 1 232 114 |
| 2023-04-28 | $0.0917 | $0.0917 | $0.0820 | $0.0830 | 443 999 |
| 2023-04-27 | $0.0816 | $0.0850 | $0.0700 | $0.0807 | 748 840 |
| 2023-04-26 | $0.0850 | $0.0885 | $0.0800 | $0.0825 | 847 898 |
| 2023-04-25 | $0.0928 | $0.0929 | $0.0847 | $0.0867 | 692 253 |
| 2023-04-24 | $0.0981 | $0.0989 | $0.0880 | $0.0900 | 793 251 |
| 2023-04-21 | $0.0900 | $0.0968 | $0.0900 | $0.0940 | 617 566 |
| 2023-04-20 | $0.0950 | $0.100 | $0.0931 | $0.0960 | 769 300 |
| 2023-04-19 | $0.101 | $0.101 | $0.0942 | $0.0950 | 868 139 |
| 2023-04-18 | $0.0990 | $0.101 | $0.0921 | $0.0987 | 1 438 146 |
| 2023-04-17 | $0.0931 | $0.102 | $0.0900 | $0.0941 | 2 243 074 |
| 2023-04-14 | $0.0970 | $0.0985 | $0.0900 | $0.0937 | 1 524 605 |
| 2023-04-13 | $0.0912 | $0.0970 | $0.0841 | $0.0959 | 2 288 466 |
| 2023-04-12 | $0.0947 | $0.0955 | $0.0910 | $0.0932 | 1 536 431 |
| 2023-04-11 | $0.100 | $0.102 | $0.0934 | $0.0942 | 1 826 183 |
| 2023-04-10 | $0.102 | $0.104 | $0.0980 | $0.100 | 1 831 666 |
| 2023-04-06 | $0.100 | $0.105 | $0.100 | $0.104 | 1 294 259 |
| 2023-04-05 | $0.108 | $0.110 | $0.0990 | $0.100 | 1 426 244 |
| 2023-04-04 | $0.110 | $0.112 | $0.103 | $0.111 | 564 970 |
| 2023-04-03 | $0.110 | $0.116 | $0.100 | $0.110 | 1 103 120 |
| 2023-03-31 | $0.120 | $0.128 | $0.107 | $0.116 | 889 283 |
| 2023-03-30 | $0.120 | $0.135 | $0.119 | $0.120 | 1 395 960 |
| 2023-03-29 | $0.118 | $0.128 | $0.118 | $0.123 | 710 929 |
| 2023-03-28 | $0.120 | $0.124 | $0.112 | $0.115 | 702 331 |
| 2023-03-27 | $0.116 | $0.127 | $0.110 | $0.120 | 752 243 |
| 2023-03-24 | $0.116 | $0.120 | $0.111 | $0.119 | 654 378 |
| 2023-03-23 | $0.125 | $0.125 | $0.113 | $0.120 | 713 362 |
About Adamis Pharmaceuticals Corporation
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emergency treatment of acute allergic reactions, including anaphylaxis; dry powder inhaler products for the ... ADMP Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
